These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10480737)

  • 1. Influence of treatment schedule and viral challenge dose on the in vivo influenza virus-inhibitory effects of the orally administered neuraminidase inhibitor GS 4104.
    Sidwell RW; Bailey KW; Bemis PA; Wong MH; Eisenberg EJ; Huffman JH
    Antivir Chem Chemother; 1999 Jul; 10(4):187-93. PubMed ID: 10480737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
    Sidwell RW; Huffman JH; Barnard DL; Bailey KW; Wong MH; Morrison A; Syndergaard T; Kim CU
    Antiviral Res; 1998 Feb; 37(2):107-20. PubMed ID: 9588843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
    Mendel DB; Tai CY; Escarpe PA; Li W; Sidwell RW; Huffman JH; Sweet C; Jakeman KJ; Merson J; Lacy SA; Lew W; Williams MA; Zhang L; Chen MS; Bischofberger N; Kim CU
    Antimicrob Agents Chemother; 1998 Mar; 42(3):640-6. PubMed ID: 9517945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors.
    Sidwell RW; Wong MH; Bailey KW; Barnard DL; Jackson MK; Smee DF
    Antivir Chem Chemother; 2001 Nov; 12(6):359-65. PubMed ID: 12018681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice.
    Burger RA; Billingsley JL; Huffman JH; Bailey KW; Kim CU; Sidwell RW
    Immunopharmacology; 2000 Apr; 47(1):45-52. PubMed ID: 10708809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor.
    Lew W; Chen X; Kim CU
    Curr Med Chem; 2000 Jun; 7(6):663-72. PubMed ID: 10702632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
    Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS
    Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
    Bantia S; Parker CD; Ananth SL; Horn LL; Andries K; Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin T; Hutchison TL; Montgomery JA; Kellog DL; Babu YS
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.
    Sidwell RW; Smee DF; Huffman JH; Barnard DL; Morrey JD; Bailey KW; Feng WC; Babu YS; Bush K
    Antiviral Res; 2001 Sep; 51(3):179-87. PubMed ID: 11448729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071.
    Li W; Escarpe PA; Eisenberg EJ; Cundy KC; Sweet C; Jakeman KJ; Merson J; Lew W; Williams M; Zhang L; Kim CU; Bischofberger N; Chen MS; Mendel DB
    Antimicrob Agents Chemother; 1998 Mar; 42(3):647-53. PubMed ID: 9517946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice.
    Sidwell RW; Smee DF; Bailey KW; Burger RA
    Int Immunopharmacol; 2001 Jun; 1(6):1211-8. PubMed ID: 11407315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamiphosphor monoesters as effective anti-influenza agents.
    Chen CL; Lin TC; Wang SY; Shie JJ; Tsai KC; Cheng YS; Jan JT; Lin CJ; Fang JM; Wong CH
    Eur J Med Chem; 2014 Jun; 81():106-18. PubMed ID: 24836064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.
    Mishin VP; Hayden FG; Gubareva LV
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4515-20. PubMed ID: 16251290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase inhibitor resistance in influenza viruses.
    Reece PA
    J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel oral anti-influenza drug candidate AV5080.
    Ivachtchenko AV; Ivanenkov YA; Mitkin OD; Yamanushkin PM; Bichko VV; Shevkun NA; Karapetian RN; Leneva IA; Borisova OV; Veselov MS
    J Antimicrob Chemother; 2014 Jul; 69(7):1892-902. PubMed ID: 24729605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraminidase inhibitors as anti-influenza virus agents.
    Kim CU; Chen X; Mendel DB
    Antivir Chem Chemother; 1999 Jul; 10(4):141-54. PubMed ID: 10480735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
    Smee DF; Wong MH; Bailey KW; Sidwell RW
    Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitors for the treatment of influenza.
    Yamashita M
    Antivir Chem Chemother; 2010; 21(2):71-84. PubMed ID: 21107016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitors: zanamivir and oseltamivir.
    McNicholl IR; McNicholl JJ
    Ann Pharmacother; 2001 Jan; 35(1):57-70. PubMed ID: 11197587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
    Hayden FG; Atmar RL; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills RG
    N Engl J Med; 1999 Oct; 341(18):1336-43. PubMed ID: 10536125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.